<DOC>
	<DOCNO>NCT02922478</DOCNO>
	<brief_summary>This study aim create database patient stable chronic heart failure comprehensive assessment bone , skeletal vascular status . RoC-HF facilitate cross-sectional , eventually , longitudinal mechanistic epidemiological analysis disentangle role bone- vascular axis chronic heart failure . Blood urine sample store facilitate future biomarker analysis .</brief_summary>
	<brief_title>Role Comorbidities Chronic Heart Failure Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporotic Fractures</mesh_term>
	<criteria>1 . Age &gt; = 18 2 . NYHA ( New York Heart Association ) class IIIV symptoms 3 . Chronic HFrEF ( Heart failure reduce ejection fraction ) define left ventricular ejection &lt; 50 % Visit 1 . 4 . Treatment accord current Heart Failure Guidelines European Society Cardiology 5 . Willingness ability provide sign informed consent form ( ICF ) prior participation studyrelated procedure 1 . Unplanned hospitalization within 1 month prior Baseline Visit . 2 . Discontinuation initiation pharmacologic device treatment HFrEF within 1 month prior baseline visit . 3 . Coronary peripheral revascularization procedure , valvular procedure , OR major surgical procedure within 3 month prior Screening Visit . 4 . Acute coronary syndrome ( ACS ) , stroke transient ischemic attack ( TIA ) within 3 month prior Screening Visit . 5 . Any acute illness 6 . Disease reduce life expectancy &lt; 1 year , except HFrEF 7 . Recipient organ transplant 8 . Primary significant valve disease ( least moderate severe valve disease )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>